SEEBRI BREEZHALER 50MCG 30 CAPSULES

SEEBRI BREEZHALER 50MCG 30 CAPSULES
Product Description
 
Seebri® Breezhaler® 44 micrograms inhalation powder, hard capsules
Each capsule contains 63 micrograms of glycopyrronium bromide equivalent to 50 micrograms of glycopyrronium.
Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 55 micrograms of glycopyrronium bromide equivalent to 44 micrograms of glycopyrronium.
Excipient(s) with known effect:
Each capsule contains 23.6 mg lactose (as monohydrate).
For the full list of excipients, see section 6.1.
Inhalation powder, hard capsule (inhalation powder).
Transparent orange capsules containing a white powder, with the product code “GPL50” printed in black above and the company logo () printed in black below a black bar.
Seebri Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
The recommended dose is the inhalation of the content of one capsule once daily using the Seebri Breezhaler inhaler.
Seebri Breezhaler is recommended to be administered, at the same time of the day each day. If a dose is missed, the next dose should be taken as soon as possible. Patients should be instructed not to take more than one dose in a day.